In PCa, MAP2K4 overexpression promotes cell proliferation and metastasis while inhibiting G1-S phase arrest and apoptosis (39, 54).Thus, miR-136 may suppress PCa proliferation and invasion by targeting MAP2K4, making it a potential candidate for PCa therapy. Here, MAP2K4 is linked to posterior cortical atrophy.